CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma

NCT01740401 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Primary Endpoint not met

Conditions

Melanoma

Interventions

DRUG: Cyclophosphamide

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]